Nicholas Piramal
Nicholas Piramal to take over UK''s Rhodia
By Mumbai: | 18 Dec 2004
Nicholas Piramal finalises product in-licensing agreement with Ethypharm, France
By Mumbai: | 18 Aug 2004
Nicholas Piramal in research collaboration with National Institute of Immunology
By Mumbai: | 12 Aug 2004
Nicholas Piramal seals an in-licensing agreement with Genzyme Corporation for the Indian market
By Mumbai: | 11 Aug 2004
Nicholas Piramal, Indian Institute of Science to develop anti-fungal drugs
By Mumbai: | 31 Mar 2004
Maneesh Nerurkar joins Nicholas Piramal as head of Formulations Research
By Dr. Maneesh Nerurkar has | 31 Mar 2004
Nicholas Piramal expands its Clinical Research facility
By Mumbai: | 24 Mar 2004
World-renowned bioscientist, Dr. Saran Narang joins Nicholas Piramal Scientific Advisory Board
By Mumbai: | 04 Mar 2004
Nicholas Piramal Q3 growth up 76.1 per cent
By Mumbai: | 07 Feb 2004
Nicholas Piramal merges Canere Actives and Fine Chemicals Pvt. Ltd.
By Mumbai: | 07 Feb 2004
Nicholas Piramal, SPPL debt programmes reaffirmed A1+
By Mumbai: | 06 Jan 2004
Nicholas Piramal buys partner''s 50% stake in Sarabhai Piramal
By Mumbai: | 26 Dec 2003
Nicholas Piramal enters into alliance with Biogen Idec, USA
By Mumbai: | 02 Dec 2003
GlaxoSmithKline declares second interim dividend of 37%
By Our Corporate Bureau | 21 Dec 2002
Nicholas Piramal net profit at Rs 311 million
By Pradeep Rane | 19 Jul 2002
Nicholas Piramal to focus on mega brands
18 Jun 2002
NPIL ropes in McKinsey for total integration
27 May 2002
GlaxoSmithkline to launch new products
By Pradeep Rane | 12 Mar 2002
Nicholas Piramal''s new business strategy
04 Mar 2002
Pharma companies in talks with MIDC
By Praveen Chandran | 13 Dec 2001
Nicholas Piramal to focus on biotech
13 Nov 2001
Nicholas Piramal-Rhone merger over
By Nisha Das | 10 Oct 2001
Nicholas Piramal to launch drug for malaria
By Ananth Iyer | 19 Feb 2000
About osteoarthritis
21 Jan 2000
Piramal drug for osteoarthritis
By Ananth Iyer | 21 Jan 2000
Featured articles
Lighter than air, yet very, very powerful
By Kiron Kasbekar | 03 Jan 2024
In March 2013 Chinese scientists pulled off a remarkable feat. They created the world’s lightest aerogel. Tipping the scales at a mere 0.16 milligrams per cubic centimeter – that’s a sixth of the weight of air!
COP28 explained: A closer look at COP28's climate change solutions
By Aniket Gupta | 27 Dec 2023
The 28th United Nations Climate Change Conference, also known as COP28, took place from 30th November 2023, to 13th December 2023, at Expo City in Dubai, United Arab Emirates.
What is a Ponzi scheme?
By Aniket Gupta | 06 Dec 2023
Ponzi schemes have long captivated the public imagination, drawing unsuspecting investors into a web of illusion and deception.
The Rise and Rise of HDFC Bank
03 Jul 2023
HDFC, which surged ahead of global majors like HSBC Holdings Plc and Citigroup Inc and left Indian peers like State Bank of India and ICICI Bank in market capitalisation, now ranks fourth largest among the world’s most valuable banks, after JPMorgan Chase & Co, Industrial and Commercial Bank of China Ltd and Bank of America Corp
India’s Millet Revolution To Enrich Global Food Basket
02 Apr 2023
Millets, a healthier and cheaper substitute to wheat and rice, are indigenous to many parts of the world, especially in the semiarid tropics of Asia and Africa, and offers a big scope for expanding production and consumption in the foodgrain deficient African continent
Market predator Hindenburg preys on Adani stock
06 Mar 2023
Almost a month after the damning report of short-seller Hindenburg Research on the Adani Group that claimed that the seven stocks within the group were about 85 per cent overvalued, one of the group's stocks, Adani Total Gas, closed at Rs835 on the BSE, down nearly 79 per cent from its 24 January level, almost close to reaching that valuation